RWMG
TNYA icon

Redwood Wealth Management Group’s Tenaya Therapeutics TNYA Stock Holding History

Redwood Wealth Management Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,600
Closed -$94.9K – 1005
2024
Q2 		$94.9K Buy
+30,600
New +$126K 0.07% 207
2024
Q1 		– Sell
-16,350
Closed -$53K – 140
2023
Q4 		$53K Buy
16,350
+4,500
+38% +$9.71K 0.06% 130
2023
Q3 		$30.2K Buy
11,850
+750
+7% +$3.14K 0.04% 137
2023
Q2 		$65.2K Hold
11,100
– – 0.07% 135
2023
Q1 		$31.6K Buy
+11,100
New +$31.2K 0.04% 149

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Redwood Wealth Management Group's TNYA Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Tenaya Therapeutics (TNYA) in Q3 2024, closing a stake of 30,600 shares — an estimated $94.9K sold.

Redwood Wealth Management Group first reported a position in TNYA in Q1 2023 and held it in 5 quarters. The position peaked at $94.9K in Q2 2024. 95 funds tracked by Wall St. Rank hold TNYA as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining Tenaya Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 30,600 Tenaya Therapeutics shares in Q3 2024, an estimated $94.9K.
  • Redwood Wealth Management Group first reported a position in Tenaya Therapeutics in Q1 2023 and held it in 5 quarters.
  • Redwood Wealth Management Group's Tenaya Therapeutics position peaked at $94.9K in Q2 2024.
  • 95 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.